Newborn Screening for Severe Combined Immunodeficiency: Analytic and Clinical Performance of the T Cell Receptor Excision Circle Assay in France (DEPISTREC Study)

Autor: Sophie Mirallié, David Cheillan, Caroline Hémont, Cécile Dert, M. Audrain, Enora M. Q. Pinel, Maxime A. G. Fournier, Véronique A. Sébille-Rivain, Aurélie M-P. Le Thuaut, Alexandra Léger, Caroline Thomas, Aurore Prat, Marie Rimbert, Eléonore Divry

Publikováno v: Journal of Clinical Immunology
Journal of Clinical Immunology, 2018, 38 (7), pp.778-786. ⟨10.1007/s10875-018-0550-7⟩
Journal of Clinical Immunology, Springer Verlag, 2018, 38 (7), pp.778-786. ⟨10.1007/s10875-018-0550-7⟩

International audience; Severe combined immunodeficiency (SCID) is characterized by a major T cell deficiency. Infants with SCID are asymptomatic at birth but die from infections in the first year of life if not treated. Survival rates are better for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd31c37da784ab2a335fc8d7c3ce202c
https://www.hal.inserm.fr/inserm-02157514/document